Skip to main content

Advertisement

Log in

Annexins in cancer and autoimmune diseases

  • Published:
Cellular and Molecular Life Sciences CMLS Aims and scope Submit manuscript

Abstract.

Several annexins have been implicated in the pathogenesis of benign and malignant neoplasms of different origins. In some tumours a suppressive action of annexins has been shown, whereas studies of other tumours indicate an involvement of annexins in tumour progression. In the light of the expression of annexins at distinct episodes of fetal development these observations point towards a functional role of annexins in cellular development and differentiation. This view is supported by data that link certain annexins to distinct pathways of signal transduction. Auto-antibodies against several annexins have been detected in patients with autoimmune diseases such as systemic lupus erythematosus, rheumatoid arthritis and inflammatory bowel disease. Until now it is unclear whether their presence reflects a relevant pathogenetic mechanism or merely represents an unspecific expression of a raised autoimmunity in these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bastian, B. Annexins in cancer and autoimmune diseases. CMLS, Cell. mol. life sci. 53, 554–556 (1997). https://doi.org/10.1007/s000180050071

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s000180050071

Navigation